Zero enrollment updateSo we have to imagine it's because zero patients have been enrolled.
Back in August they told us 4 trial sites would be added by end of 2022. And they said 20 would be enrolling by the end of this month.
No matter how tiny the pledge- Seto and Kellum seem to find a way to come up well short.
PS I wonder if Kellum had to be given extra performance options to shoehorn in schlocky adjectives like "acclerate", "rapidly" and "swiftly" to describe a stalled trial?